Auroca Cannabis has launched Bidiol, a medical CBD oil in Uruguay that is also manufactured in the country.
Shares of Aurora Cannabis (ACB) rose 3.2% in early trading Tuesday after the company posted lower sales, but a smaller loss in the fourth quarter of 2021 than a year...
The past, present, and future of the Canadian cannabis sector that's based on the performance of the MCCCI, which is a proprietary 23 stock index.
Aurora Cannabis Inc. reported its financial and operational results yesterday for the fourth quarter ended June 30, 2021.
Aurora Cannabis investors prepare for the full fiscal year 2021 earnings and investor conference call. The stock price is down by 28.40% YTD.
Aurora Cannabis Inc. produces, distributes, and sells cannabis and cannabis derivative products in Canada and internationally. It also engages in facility engineering and design, cannabis breeding, research, production, derivatives, product development, wholesale, and retail distribution activities. The company produces various strains of dried cannabis, cannabis oil and capsules, and topical kits for medical patients. It also sells vaporizers; consumable vaporizer accessories; and herb mills for using CanniMed herbal cannabis products, as well as grinders and vaporizer lockable containers. In addition, the company engages in the development of medical cannabis products at various stages of development, including oral, topical, edible, and inhalable products; and operation of CanvasRX, a network of cannabis counseling and outreach centers. Further, it provides patient counselling services; design and construction services; and cannabis analytical product testing services. The company's brand portfolio includes Aurora, Aurora Drift, San Rafael '71, Daily Special, AltaVie, MedReleaf, CanniMed, Whistler, Woodstock, and WMMC. Aurora Cannabis Inc. is headquartered in Edmonton, Canada.